GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » Price-to-Free-Cash-Flow

Motus GI Holdings (Motus GI Holdings) Price-to-Free-Cash-Flow : N/A (As of Apr. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings Price-to-Free-Cash-Flow?

As of today (2024-04-25), Motus GI Holdings's share price is $0.077. Motus GI Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-24.79. Hence, Motus GI Holdings's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Motus GI Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

MOTS's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 31.73
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Motus GI Holdings's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-1.20. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-24.79.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 55.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 42.30% per year.

During the past 9 years, Motus GI Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was 55.60% per year. The lowest was -16.40% per year. And the median was 31.40% per year.


Motus GI Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for Motus GI Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings Price-to-Free-Cash-Flow Chart

Motus GI Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

Motus GI Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Motus GI Holdings's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Motus GI Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Motus GI Holdings's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's Price-to-Free-Cash-Flow falls into.



Motus GI Holdings Price-to-Free-Cash-Flow Calculation

Motus GI Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.077/-24.786
=N/A

Motus GI Holdings's Share Price of today is $0.077.
Motus GI Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Motus GI Holdings  (OTCPK:MOTS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Motus GI Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Motus GI Holdings (Motus GI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
Executives
Orchestra Biomed Holdings, Inc. 10 percent owner 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin director PO BOX 376, ANN ARBOR MI 48106
Elad Amor officer: Chief Accounting Officer MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram officer: Chief Financial Officer MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran director, officer: Chief Executive Officer C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor officer: Chief Financial Officer C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz director, officer: President and COO C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson director C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp other: * See Remarks 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg other: * See Remarks C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman director C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman director, other: Chairman of the Board 15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy director 850 PARK AVENUE, APT. 12B, NEW YORK NY 10075